Aardvark Therapeutics, Inc. Common Stock (AARD) NASDAQ
4.90
+0.02(+0.41%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.90
+0.02(+0.41%)
Currency In USD
| Market Cap | 184.73M |
| Enterprise Value | 123.87M |
| P/E Ratio | -2.18 |
| PEG Ratio | 0.12 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.87 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.31 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.37 |
| Return On Equity | -0.55 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -22.65M |
| Net Income | -20.59M |
| Diluted EPS | -1.59 |
| Total Cash | 126.35M |
| Total Cash/Share | 5.82 |
| Total Debt | 545,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 12.03 |
| Book Value Per Share | 5.64 |
| 52-Week Change | -48.91 |
| 52-Week High | 17.94 |
| 52-Week Low | 4.74 |
| Moving Average 50 Days | 11.42 |
| Moving Average 200 Days | 11.82 |
| Average Volume | 270,040 |
| Shares Outstanding | 21.77M |
| % Held by Institutions | 49.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |